Prevalence of cardiovascular diseases and traditional cardiovascular risk factors in patients with rheumatoid arthritis: a real?life evidence from BioSTAR nationwide registry

Basit Öğe Kaydı
dc.authorid0000-0003-3584-2788en_US
dc.authorid0000-0003-3570-3825en_US
dc.authorid0000-0003-3008-7007en_US
dc.authorid0000-0001-5466-7482en_US
dc.authorid0000-0001-7519-9470en_US
dc.authorid0000-0003-3012-2968en_US
dc.authorid0000-0003-2728-5934en_US
dc.authorid0000-0001-8287-2264en_US
dc.authorid0000-0002-4124-1586en_US
dc.contributor.authorDuruöz, Mehmet Tuncay
dc.contributor.authorAtaman, Şebnem
dc.contributor.authorBodur, Hatice
dc.contributor.authorÇay, Hasan Fatih
dc.contributor.authorMelikoğlu, Meltem Alkan
dc.contributor.authorAkgül, Özgür
dc.contributor.authorÇapkın, Erhan
dc.contributor.authorGürer, Gülcan
dc.contributor.authorÇevik, Remzi
dc.date.accessioned2024-03-27T06:21:24Z
dc.date.available2024-03-27T06:21:24Z
dc.date.issued2024en_US
dc.departmentDicle Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Fizik Tedavi ve Rehabilitasyon Ana Bilim Dalıen_US
dc.description.abstractPatients with rheumatoid arthritis (RA) have increased morbidity and mortality due to cardiovascular (CV) comorbidities. The association of CV diseases (CVD) and traditional CV risk factors has been debated, depending on patient and RA characteristics. This study aimed to find the prevalence of CVD and CV risk factors in patients with RA. A multi-center cross-sectional study was performed on RA patients using the BioSTAR (Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs Registry) in September 2022. Socio-demographic, clinical, and follow-up data were collected. Myocardial infarction, ischemic heart disease, peripheral vascular disorders, congestive heart failure, ischemic stroke, and transient ischemic attack were regarded as major adverse cardiovascular events (MACEs). CVD was defined as the presence of at least one clinical situation of MACE. Group 1 and Group 2 included patients with and without CVD. Prevalence rates of CVD and traditional CV risk factors were the primary outcomes. Secondary outcomes were the differences in the clinical characteristics between patients with and without CVD. An analysis of 724 patients with a mean age of 55.1 ± 12.8 years diagnosed with RA was conducted. There was a female preponderance (79.6%). The prevalence rate of CVD was 4.6% (n = 33). The frequencies of the diseases in the MACE category were ischemic heart disease in 27, congestive heart failure in five, peripheral vascular disorders in three, and cerebrovascular events in three patients. The patients with CVD (Group 1) were significantly male, older, and had higher BMI (p = 0.027, p < 0.001, and p = 0.041). Obesity (33.4%) and hypertension (27.2%) were the two CV risk factors most frequently. Male sex (HR = 7.818, 95% CI 3.030–20.173, p < 0.001) and hypertension (HR = 4.570, 95% CI 1.567–13.328, p = 0.005) were the independent risk factors for CVD. The prevalence of CVD in RA patients was 4.6%. Some common risk factors for CVD in the general population, including male sex, older age, and hypertension, were evident in RA patients. Male sex and hypertension were the independent risk factors for developing CVD in patients with RA.en_US
dc.identifier.citationDuruöz, M. T., Ataman, Ş., Bodur, H., Çay, H. F., Melikoğlu, M. A., Akgül, Ö. ve diğerleri. (2024). Prevalence of cardiovascular diseases and traditional cardiovascular risk factors in patients with rheumatoid arthritis: a real‑life evidence from BioSTAR nationwide registry. Rheumatology International, 44(2), 291-301en_US
dc.identifier.doi10.1007/s00296-023-05515-y
dc.identifier.endpage301en_US
dc.identifier.issn0172-8172
dc.identifier.issue2en_US
dc.identifier.pmid38157014
dc.identifier.scopus2-s2.0-85180894310
dc.identifier.scopusqualityQ1
dc.identifier.startpage291en_US
dc.identifier.urihttps://link.springer.com/article/10.1007/s00296-023-05515-y
dc.identifier.urihttps://hdl.handle.net/11468/13744
dc.identifier.volume44en_US
dc.identifier.wosWOS:001132625000001
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthorÇevik, Remzi
dc.language.isoenen_US
dc.publisherSpringer Science and Business Media Deutschland GmbHen_US
dc.relation.ispartofRheumatology International
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCardiovascular risken_US
dc.subjectComorbidityen_US
dc.subjectMajor adverse cardiac eventsen_US
dc.subjectPrevalenceen_US
dc.subjectRheumatoid arthritisen_US
dc.subjectSecondary disease preventionen_US
dc.titlePrevalence of cardiovascular diseases and traditional cardiovascular risk factors in patients with rheumatoid arthritis: a real?life evidence from BioSTAR nationwide registryen_US
dc.titlePrevalence of cardiovascular diseases and traditional cardiovascular risk factors in patients with rheumatoid arthritis: a real?life evidence from BioSTAR nationwide registry
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
Prevalence of cardiovascular diseases and traditional cardiovascular risk factors in patients.pdf
Boyut:
585.82 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Makale Dosyası
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Dahili Tıp Bilimleri Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu